e-learning
resources
Glasgow 2004
Monday 06.09.2004
Drug therapy of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of inhaled salt-bromide-iodine thermal water on airway inflammation in COPD
M. Pellegrini, D. Fanin, Y. Nowiki, G. Guarnieri, A. Bordin, P. Maestrelli (Padova, Italy)
Source:
Annual Congress 2004 - Drug therapy of COPD
Session:
Drug therapy of COPD
Session type:
Thematic Poster Session
Number:
1870
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Pellegrini, D. Fanin, Y. Nowiki, G. Guarnieri, A. Bordin, P. Maestrelli (Padova, Italy). Effect of inhaled salt-bromide-iodine thermal water on airway inflammation in COPD. Eur Respir J 2004; 24: Suppl. 48, 1870
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Related content which might interest you:
Airway inflammation and inhaled corticosteroids in COPD
Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017
Year: 2017
Effects of corticosteroids on airway inflammation in cough variant asthma
Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring
Year: 2004
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017
Year: 2017
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016
Year: 2017
Thermal spring water reduces the airway inflammation in patients with chronic bronchitis
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008
Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Influence of endogenous corticosteroids on bronchial protective properties of β
2
-agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010
Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017
Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 670s
Year: 2006
Effects of inhaled corticosteroids on breath condensate inflammatory markers in childhood asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 41s
Year: 2005
Effects of active and passive smoking on allergic airway inflammation and airway hyperresponsiveness in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 310s
Year: 2002
Influence of controller therapy with extrafine beclometasone/formoterol on the quality of life of asthma patients with cold and/or osmotic airway hyperresponsiveness
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
Influence of
ADRB2
gene polymorphism on cold airway hyperresponsiveness and asthma control depending on inhaled glucocorticoids use
Source: Annual Congress 2012 - Gene-environment treatment and asthma
Year: 2012
Airway inflammation and airway dynamics during deep inspiration in asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 831s
Year: 2006
Dose response for inhaled fluticasone on airway and systemic inflammation in COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Dose–response for inhaled fluticasone on airway and systemic inflammation in COPD
Source: Eur Respir J 2011; 37: 206-209
Year: 2011
Modulation of chronic airway inflammation by oral tolerance: effects in lung mechanics, exhaled nitric oxide and airway hyperresponsiveness to methacholine in guinea pigs
Source: Eur Respir J 2003; 22: Suppl. 45, 484s
Year: 2003
Effects of water aerosol on pediatric allergic asthma
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012
Effects of fluticasone and ciclesonide on pulmonary function and airway inflammation in stable mild asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept